Search This Blog

Tuesday, June 5, 2018

Amedisys target upped by Oppco


Amedisys price target raised to $85 from $77 at Oppenheimer. Oppenheimer analyst Michael Wiederhorn raised his price target for Amedisys to $85 from $77 on 6%-7% accretive share repurchase. The analyst reiterates an Outperform rating on the shares.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)